|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
EBSCO_ocn835630640 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
130404s2012 nyu o 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d E7B
|d OCLCF
|d EBLCP
|d OCLCQ
|d D6H
|d VTS
|d TOF
|d AU@
|d STF
|d OCLCQ
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781621006428
|q (electronic bk.)
|
| 020 |
|
|
|a 1621006425
|q (electronic bk.)
|
| 029 |
1 |
|
|a DEBBG
|b BV041049539
|
| 029 |
1 |
|
|a DEBBG
|b BV043775648
|
| 029 |
1 |
|
|a DEBSZ
|b 472781340
|
| 035 |
|
|
|a (OCoLC)835630640
|
| 050 |
|
4 |
|a RC46
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Advances in medicine and biology.
|n Volume 41 /
|c Leon V. Berhardt, editor.
|
| 260 |
|
|
|a New York :
|b Nova Science Publishers,
|c ©2012.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in medicine and biology
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Title page of PDF version (Ebsco; April 4, 2013).
|
| 505 |
0 |
|
|a ADVANCES IN MEDICINE AND BIOLOGY VOLUME 41 ; ADVANCES IN MEDICINE AND BIOLOGY VOLUME 41 ; Contents; Preface ; Muscarinic and Nicotinic Receptors as Drug Targets in Disorders of the Central Nervous System ; Abstract ; Introduction; Acetylcholine and Cognition ; Cholinoceptors ; Muscarinic Receptors ; Nicotinic Receptors ; Schizophrenia ; Acetylcholine and the Treatment of Schizophrenia ; Muscarinic Receptors in Schizophrenia ; Muscarinic Antagonists and Schizophrenia ; Muscarinic Agonists in Schizophrenia ; Nicotinic Receptors in Schizophrenia ; Nicotinic Agonists in Schizophrenia.
|
| 505 |
8 |
|
|a Bipolar Disorder and Major Depressive DisorderAcetylcholine and the Treatment of Mood Disorders ; Muscarinic Receptors in Mood Disorders; Muscarinic Agonists in Mood Disorders ; Nicotinic Receptors in Mood Disorders ; Nicotinic Antagonists in Mood Disorders ; Alzheimer's Disease ; Acetylcholine and the Treatment of Alzheimer's Disease ; Muscarinic Receptors in Alzheimer's Disease; Muscarinic Agonists in Alzheimer's Disease ; Nicotinic Receptors in Alzheimer's Disease ; Nicotinic Agonists in Alzheimer's Disease ; Parkinson's Disease; Acetylcholine and the Treament of Parkinson's Disease.
|
| 505 |
8 |
|
|a Muscarinic Receptors in Parkinson's Disease Muscarinic Antagonists in Parkinson's Disease ; Nicotinic Receptors in Parkinson's Disease; Nicotinic Agonists in Parkinson's Disease; Conclusion ; References ; Immune Modulation for Treatment of HSV ; Abstract ; Introduction; Herpes Simplex Virus; HSV MMorpholoogy ; Cellular Attachment and Entry; Life Cycle of HSV; Nucleoside Analogues and Current Treatment Options of HSV ; Acyclovir and Analogues; Stimulating Host Immunity ; Host Antimicrobial Proteins; Antimicrobial Host Defence Peptides ; Blocking of Viral Entry.
|
| 505 |
8 |
|
|a Blocking Viral Cell-to-Cell Spread Lysis of the Viral Envelope; Host Immune Modulation ; Pharmacutical Potential ; Combination Therapy ; References ; Pulmonary Edema: State of the Art and a New Approach to Its Diagnosis/Treatment ; Abstract ; 1. Introduction ; 1.1. Pulmonary Edema ; 1.1.1. Water and Macromolecule Exchange in the Lung ; 1.1.2. Functional Anatomy ; 1.1.3. Ultrastructural Anatomy ; 1.1.4. Lymphatic Drainage ; 1.1.5. Water Excess in the Lungs -- Evaluation Techniques ; 1.1.6. Experimental Models of Pulmonary Edema ; 1.2. Liposomes ; 1.2.1. Liposomes as Drug Delivery Systems.
|
| 505 |
8 |
|
|a 1.2.2. Characteristics of Liposomes 1.2.3. Classification of Liposomes and Production Techniques; 1.2.4. Liposome -- Potential Role for Diagnosis and Therapy ; 1.2.5. Radiolabelling Procedures of Liposomes ; 2. Material and Methods ; 2.1. Methodology ; 2.2. Dedicated Drug Delivery System ; 2.3. Encapsulated Radiotracers ; 2.3.1. Radionuclide -- 99mTc ; 2.3.2. Radiopharmaceuticals ; 2.3.3. Statistical Analysis ; 2.4. Animal Experimental Model -- Biological Studies ; 2.4.1. Cardiogenic Pulmonary Edema; 2.4.2. Non-Cardiogenic Pulmonary Edema; 3. Results and Discussion ; Conclusion.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Clinical medicine.
|
| 650 |
|
0 |
|a Biology.
|
| 650 |
|
2 |
|a Clinical Medicine
|
| 650 |
|
2 |
|a Biology
|
| 650 |
|
6 |
|a Médecine clinique.
|
| 650 |
|
6 |
|a Biologie.
|
| 650 |
|
7 |
|a biology.
|2 aat
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Biology
|2 fast
|
| 650 |
|
7 |
|a Clinical medicine
|2 fast
|
| 700 |
1 |
|
|a Berhardt, Leon V.
|
| 830 |
|
0 |
|a Advances in medicine and biology.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=535140
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3021411
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10683069
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 535140
|
| 994 |
|
|
|a 92
|b IZTAP
|
